Regulation & Policy (Pharma & Healthcare)


Publication Single User License (PDF) Price
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Republic of China (Taiwan)

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Republic of China (Taiwan)

Date Published: Jun 11 2015

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Republic of China (Taiwan)

Summary

$1,995.00
Global Medical Waste Management Market 2015-2019

Global Medical Waste Management Market 2015-2019

Date Published: Jun 10 2015
Report forecast the global medical waste management market to grow at a CAGR of 5.35% over the period 2014-2019.
 
$2,500.00
PharmaSphere: North American Market Access Strategy

PharmaSphere: North American Market Access Strategy

Date Published: Jun 1 2015

PharmaSphere: North American Market Access Strategy

Summary

$2,995.00
PharmaSphere: Emerging Biotechnologies - Gene Therapy Market Analysis

PharmaSphere: Emerging Biotechnologies - Gene Therapy Market Analysis

Date Published: Jun 1 2015

PharmaSphere: Emerging Biotechnologies - Gene Therapy Market Analysis

Summary

$2,995.00
Partnerships, Licensing, Investments and M&A Deals and Trends for April 2015 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for April 2015 in Pharmaceuticals

Date Published: Jun 1 2015

Partnerships, Licensing, Investments and M&A Deals and Trends for April 2015 in Pharmaceuticals

Summary

$1,000.00
Latest Chinese Guidance for Development, Evaluation, License Approval of Biosimilars

Latest Chinese Guidance for Development, Evaluation, License Approval of Biosimilars

Date Published: May 18 2015

Responding to strong desire of overseas and multinational pharmaceutical manufacturers and domestic pharmaceutical manufacturers to carry out research and development of biosimilar products, this is first time in history, Chinese pharmaceutical authorities, China Food and Drug Administration officially issued a technical guidance for development and evaluation of biosimilars and defined the pathway of license approval for biosimilars.

$750.00
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2015

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2015

Date Published: May 4 2015

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2015

Summary

$1,500.00
Partnerships, Licensing, Investments and M&A Deals and Trends for 2014 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for 2014 in Pharmaceuticals

Date Published: May 1 2015

Partnerships, Licensing, Investments and M&A Deals and Trends for 2014 in Pharmaceuticals

Summary

$3,500.00
Partnerships, Licensing, Investments and M&A Deals and Trends for March 2015 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for March 2015 in Pharmaceuticals

Date Published: May 1 2015

Partnerships, Licensing, Investments and M&A Deals and Trends for March 2015 in Pharmaceuticals

Summary

$1,000.00
Atovaquone, Proguanil  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Atovaquone, Proguanil - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Date Published: Apr 16 2015

Atovaquone, Proguanil - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) Prophylaxis and treatment of Plasmodium falciparum malaria GlaxoSmithKline (Malarone)

Report Summary
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. !NOW WITH ‘USA VIEW’!

$600.00
Doxercalciferol  - Comprehensive patent search

Doxercalciferol - Comprehensive patent search

Date Published: Apr 16 2015

Doxercalciferol - Comprehensive patent search Secondary hyperparathyroidism Genzyme (Hectorol); Draxis (Hectorol); Shire (Hectorol)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$7,500.00
Escitalopram  - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

Escitalopram - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

Date Published: Apr 16 2015

Escitalopram - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries) Treatment of major depressive episodes; Treatment of panic disorder with or without agoraphobia; Treatment of social anxiety disorder; Treatment of generalised anxiety disorder; Treatment of obsessive-compulsive disorder
Forest Labs (Lexapro); Lundbeck (Cipralex); Lundbeck (Lexapro); Alphapharm (Loxalate); Aspen (Lexam); CNS Pharma (Esipram); CNS Pharma (Metopram); Sandoz (Esitalo); Eris Pharm (Cilopam-S); Lupin (Escital); Actavis (Escipro)

$1,400.00
Aflibercept  - Comprehensive patent search

Aflibercept - Comprehensive patent search

Date Published: Apr 16 2015

Aflibercept - Comprehensive patent search Treatment of neovascular wet age-related macular degeneration; Treatment of macular edema following central retinal vein occlusion; Treatment of metastatic colorectal cancer that is resistant to or has progressed following an Oxaliplatin-containing regimen in combination with 5-Fluorouracil, Leucovorin and Irinotecan Regeneron (Eylea); Sanofi (Zaltrap, Lidaveg, Aflitiv); Bayer (Eylea)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$9,300.00
Abacavir  - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

Abacavir - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

Date Published: Apr 16 2015

Abacavir - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries) In combination with other antiretroviral agents, indicated for the treatment of HIV-1 infection. GSK (Ziagen, Trizivir, Epzicom, Kivexa)

Report Summary
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. !NOW WITH ‘USA VIEW’!

$1,400.00
Lixisenatide  - Comprehensive patent search

Lixisenatide - Comprehensive patent search

Date Published: Apr 16 2015

Lixisenatide - Comprehensive patent search Treatment of type 2 diabetes mellitus optionally in combination with Insulin glargine, basal Insulin and/or other antidiabetics Sanofi (Lyxumia)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$7,500.00
Simvastatin  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Simvastatin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Date Published: Apr 16 2015

Simvastatin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) Hypercholesterolemia, Hyperlipidemia Merck (Zocor, Lipex, Simvar)

Report Summary
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. !NOW WITH ‘USA VIEW’!

$600.00
Bepotastine  - Comprehensive patent search

Bepotastine - Comprehensive patent search

Date Published: Apr 16 2015

Bepotastine - Comprehensive patent search Treatment of itching associated with allergic conjunctivitis Ista Pharm (Bepreve)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$6,200.00
Clevidipine  - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

Clevidipine - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

Date Published: Apr 16 2015

Clevidipine - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries) Short term treatment of hypertension Medicines Co (Cleviprex); Kendle (Cleviprex)

Report Summary
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. !NOW WITH ‘USA VIEW’!

$1,400.00
Silodosin  - Comprehensive patent search

Silodosin - Comprehensive patent search

Date Published: Apr 16 2015

Silodosin - Comprehensive patent search Benign prostatic hypertropy Kissei (Urief); Watson (Rapaflo)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$6,200.00
Eprosartan, Hydrochlorothiazide  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Eprosartan, Hydrochlorothiazide - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Date Published: Apr 16 2015

Eprosartan, Hydrochlorothiazide - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) Treatment of hypertension Abbott (Teveten); Abbvie (Teveten); Solvay (Teveten)

Report Summary
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. !NOW WITH ‘USA VIEW’!

$600.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data